Labetalol in resistant hypertension
Stern, N.; Teicher, A.; Rosenthal, T.
Harefuah 101(3-4): 54-56
1981
ISSN/ISBN: 0017-7768 PMID: 7319385 Document Number: 181314
Document emailed within 1 workday
Related Documents
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Harvald, B. 1980: Comparison of labetalol and propranolol in treatment of hypertension Postgraduate Medical Journal 56(Suppl 2): 65-68
1981: A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group New Zealand Medical Journal 93(681): 215-218
Bonavita, E. 1984: Combined labetalol plus flunarizine treatment for arterial hypertension International Journal of Clinical Pharmacology Research 4(6): 475-480
Benchimol, A.B.; Sbissa, A.S.; Benchimol, C.B.; Saad, E.A.; Barbosa, E.T.; Albanesi Filho, F.M.; Pillegi, F.; da Cunha, G.P.; Maranhão, M.F.; Batlouni, M.; Schlesinger, P.; Duprat, R.; Maciel, R. 1982: Labetalol in the treatment of arterial hypertension. a Brazilian multicenter study Arquivos Brasileiros de Cardiologia 38(5): 421-427
Dubois, D.; Petitcolas, J.; Temperville, B.; Klepper, A.; Leboullenger, P. 1984: Treatment of arterial hypertension in the pregnant woman with labetalol. a propos of 24 cases Journal de Gynecologie Obstetrique et Biologie de la Reproduction 13(6): 691-700
Rumboldt, Z.; Bagatin, J.; Vidovic, A. 1983: Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension International Journal of Clinical Pharmacology Research 3(1): 47-54
Gumułka, W.S.; Zalewska-Rutczyńska, Z. 1984: The effect of labetalol and propranolol on the development of hypertension in spontaneously hypertensive rats Acta Physiologica Polonica 35(1): 41-46
Darmansjah, I.; Setiawati, A.; Prabowo, P.; Sukandar, E.; Parsoedi, I.; Ardaya; Bahry, B.; Jusman, J.; Anggraeni, E. 1995: A dose-ranging study of labetalol in moderate to moderately severe hypertension International Journal of Clinical Pharmacology and Therapeutics 33(4): 226-231
Pedersen, E.B.; Larsen, J.S. 1980: Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension Postgraduate Medical Journal 56(Suppl 2): 27-32
Rossi, A.; Ziacchi, V.; Lomanto, B. 1979: Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol Archives des Maladies du Coeur et des Vaisseaux 72(11): 1240-1246
Barnett, A.J.; Kalowski, S.; Guest, C. 1978: Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study Medical Journal of Australia 1(2): 105-109
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Sirivanasandha, B.; Sakaew, A.; Sutthivaiyakit, K.; Raksamani, K.; Waitayawinyu, P.; Rushatamukayanunt, P.; Punkla, W. 2015: An Equivalence Trial Comparing Labetalol and Diltiazem in Controlling Emergence Hypertension after Supratentorial Tumor Surgery Journal of the Medical Association of Thailand 98(11): 1104-1111
Plouin, P.F.; Bréart, G.; Maillard, F.; Papiernik, E.; Relier, J.P. 1987: Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial Archives des Maladies du Coeur et des Vaisseaux 80(6): 952-955
Forette, F.; Henry-Amar, M.; d'Allens, H.; Hervy, M.P.; Bouchacourt, P.; Henry, J.F.; Pappo, M. 1987: Arterial hypertension in the elderly. Double-blind study versus placebo of the efficacy and tolerability of an alpha-beta blocker: labetalol Annales de Cardiologie et d'Angeiologie 36(2): 103-107
Tiwaskar, M. 2016: Hypertension Control in India: Are we there Yet? OR Uncontrolled and Resistant Hypertension: the Indian Perspective Journal of the Association of Physicians of India 64(7): 11-12
Gulati, S.; Gulati, S. 2014: Resistant Hypertension Journal of the Association of Physicians of India 62(9 Suppl): 17-25
Chahal, N.S.; Senior, R. 2010: Resistant hypertension: evaluation and treatment Indian Heart Journal 62(5): 407-409